Greg Skipper, MD, Medical Director and Medical Review Officer
Dr. Skipper is currently the Medical Director of the Alabama Physician Health Program and an Assistant Professor of Medicine at the University of Alabama School of Medicine. He is certified in Internal Medicine and is a Fellow of the American Society of Addiction Medicine. Dr. Skipper has worked in the arena of physician health and medical staff administration for more than 25 years.
He is a certified Medical Review Officer and is internationally recognized as an expert in drug testing and toxicology. Prior to returning to his home state of Alabama in 1999 he was on the faculty at the Oregon Health Sciences University for twenty years.
Dr. Skipper was appointed in 2002 by the Secretary of HHS to the National Advisory Council overseeing Drug Treatment in the United States and to the FDA’s Center for Drug Evaluation and Research overseeing policies regarding drugs of abuse.
Dr. Skipper helped innovate and develop ethylglucuronide, EtG, testing in the United States, and has published and testified widely regarding this new test. He maintains an informational website, www.ethylglucuronide.com, regarding the test. Dr. Skipper is a Principle Investigator in a National Study of Physician Health Programs in the United States, sponsored by a Robert Wood Johnson Foundation grant. This study aims to analyze the structure and function of Physician Health Programs and to assess their effectiveness with an eye toward utilizing components of these model programs to enhance treatment outcomes.
Dr. Skipper has published widely in Addiction Medicine both in books and peer review journals and speaks frequently, both nationally and internationally, regarding various aspects of addiction treatment, drug testing, ethics, and behavior among professionals. He has appeared on the Jim Lehrer News Hour, the Today Show, and other media venues and has been featured in the Wall Street Journal and other newspapers.